CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Citing positive developments in its development programs, analysts from a couple of investment banks think CRISPR Therapeutics(NASDAQ: CRSP) could more than double your money in the year ahead. Start ...

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using ...

Princess Kate Middleton opened up about the side effects of chemo when she visited the Royal Marsden Hospital in London, ...

Local pastor, father to a four-year-old daughter, and educator fights cancer for the third time. Shreveport/Bossier native ...

Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG ...

13 January 2025, 17:45 Nawaf Salam received 85 votes in the parliamentary consultations to name a new PM, as Mikati received nine votes and 34 MPs refrained from naming anyone. 13 January 2025, 17:43 ...

Photo shows Dozens of police stand outside the South Korean presidential residence next to a bus being used as a blockade ...

The company anticipates launching three CRISPR products by 2030, including therapies for hereditary angioedema and ...